AKT1 and Insulin resistance: Trilobatin significantly reduced the high fasting glucose level and improved insulin resistance of KK-Ay mice, promoted Nrf2 nucleus translocation and increased the antioxidant protein expressions of HO-1 and NQO-1, while upregulating the phosphorylation levels of Akt and GSK-3 and GLUT-2 protein expression [33].